Xylem Inc. (NYSE:XYL) Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale reduced its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 1.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,628,489 shares of the industrial products company's stock after selling 27,880 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.67% of Xylem worth $192,278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of Xylem by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after acquiring an additional 303,854 shares during the last quarter. Geode Capital Management LLC raised its holdings in Xylem by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock valued at $671,623,000 after buying an additional 135,492 shares during the period. Royal Bank of Canada raised its holdings in Xylem by 7.9% during the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after buying an additional 320,500 shares during the period. Invesco Ltd. raised its holdings in Xylem by 9.8% during the 4th quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock valued at $465,229,000 after buying an additional 359,276 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock valued at $435,119,000 after buying an additional 301,070 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Down 0.7%

NYSE:XYL traded down $0.96 during mid-day trading on Friday, hitting $130.64. The stock had a trading volume of 270,429 shares, compared to its average volume of 1,544,545. The stock has a 50-day simple moving average of $126.86 and a two-hundred day simple moving average of $122.47. The company has a market capitalization of $31.79 billion, a PE ratio of 35.12, a PEG ratio of 2.39 and a beta of 1.12. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $143.50. The company has a current ratio of 1.89, a quick ratio of 1.41 and a debt-to-equity ratio of 0.18.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, topping analysts' consensus estimates of $0.95 by $0.08. Xylem had a net margin of 10.54% and a return on equity of 10.12%. The company had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. During the same quarter last year, the company earned $0.90 earnings per share. The firm's revenue for the quarter was up 1.8% on a year-over-year basis. On average, equities research analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were given a dividend of $0.40 per share. The ex-dividend date was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a yield of 1.22%. Xylem's payout ratio is currently 43.01%.

Analyst Ratings Changes

A number of analysts have weighed in on the company. JPMorgan Chase & Co. assumed coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 target price on the stock. Stifel Nicolaus raised their price objective on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research report on Wednesday, April 30th. Robert W. Baird dropped their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Finally, Royal Bank Of Canada lifted their target price on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a report on Wednesday, April 30th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $143.71.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.